Search results
Rituximab Tied to Increased Infection Risk in RRMS
Medscape· 4 days agoThe B-cell–depleting treatment rituximab was associated with a twofold increased risk for infection in RRMS, regardless of treatment duration or whether the patient had received other DMTs first.